2,10,11-trihydroxy-n-n-propylnoraporphine and Ocular Hypertension

2,10,11-trihydroxy-n-n-propylnoraporphine has been researched along with Ocular Hypertension in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, TC; Ogidigben, M; Potter, DE	1

Other Studies

1 other study(ies) available for 2,10,11-trihydroxy-n-n-propylnoraporphine and Ocular Hypertension

Article	Year
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2 Topics: Animals; Aporphines; Aqueous Humor; Cats; Ciliary Body; Cyclic AMP; Dopamine Agents; Drug Interactions; Eye; Female; Intraocular Pressure; Iris; Male; Metoclopramide; Nictitating Membrane; Norepinephrine; Ocular Hypertension; Ocular Hypotension; Rabbits; Sympathectomy; Tritium; Water	1993

Article

Year

Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.

The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

Topics: Animals; Aporphines; Aqueous Humor; Cats; Ciliary Body; Cyclic AMP; Dopamine Agents; Drug Interactions; Eye; Female; Intraocular Pressure; Iris; Male; Metoclopramide; Nictitating Membrane; Norepinephrine; Ocular Hypertension; Ocular Hypotension; Rabbits; Sympathectomy; Tritium; Water

1993